Skip to content

Evaluation of clinical value of breath molecular diagnosis with oral-cecal transit time

Evaluation of clinical value of breath molecular diagnosis with oral-cecal transit time

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400089793
Enrollment
Unknown
Registered
2024-09-14
Start date
2024-09-30
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

functional gastrointestinal diseases

Interventions

Observation Group:Measure oral-cecal transit time

Sponsors

The Second Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1: Age 18-65 years old, gender not limited. 2: Capable of autonomous ability, able to sign informed consent forms as required, able to independently or with the assistance of researchers, complete gastrointestinal symptom scoring and methane and hydrogen breath tests.

Exclusion criteria

Exclusion criteria: 1: History of organic digestive tract diseases 2: istory of abdominal surgery 3: History of nutritional malabsorption 4: History of endocrine and metabolic disorders 5: History of neurological disorders 6: History of muscle disease 7: Long term use of antidepressants, sleep aids, hypoglycemic and lipid-lowering drugs for patients 8: Pregnant, lactating women, or those with poor overall compliance, or other situations that researchers consider necessary to exclude

Design outcomes

Primary

MeasureTime frame
oral-cecal transit time;

Countries

China

Contacts

Public ContactWu Honglei

The Second Hospital of Shandong University

whl20011996@163.com+86 176 6008 0767

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026